These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8041372)

  • 1. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
    Lew MF; Shindo M; Moskowitz CB; Wilhelmsen KC; Fahn S; Waters CH
    Mov Disord; 1994 May; 9(3):318-20. PubMed ID: 8041372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of laryngeal dystonia associated with neurosyphilis: Response to botulinum toxin injection.
    Ho KH; Wright CC; Underbrink MP
    Laryngoscope; 2011 Jan; 121(1):147-9. PubMed ID: 21154825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
    Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
    Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-associated hemifacial dystonia.
    Mark MH; Sage JI
    Mov Disord; 1991; 6(4):383. PubMed ID: 1758464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lubag syndrome (Xq13-linked dystonia-parkinsonism)].
    Ishikawa A
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):148-50. PubMed ID: 10434615
    [No Abstract]   [Full Text] [Related]  

  • 8. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
    Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belly dystonia induced by levodopa and biperiden in a case of suspected multiple-system atrophy.
    Shan DE; Kwan SY; Ho HH; Su MS
    Mov Disord; 1996 Jul; 11(4):455-7. PubMed ID: 8813234
    [No Abstract]   [Full Text] [Related]  

  • 10. Sleep-related adductor laryngeal dystonia causing sleep apnea: a sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin.
    Marchese-Ragona R; Vianello A; Restivo DA; Pittoni G; Lionello M; Martini A; Manfredini D; Kotecha B; Staffieri A
    Laryngoscope; 2013 Jun; 123(6):1560-3. PubMed ID: 23666585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa can worsen tremor associated with dystonia.
    Hensman DJ; Bain PG
    Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mapping of "Lubag" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome.
    Wilhelmsen KC; Weeks DE; Nygaard TG; Moskowitz CB; Rosales RL; dela Paz DC; Sobrevega EE; Fahn S; Gilliam TC
    Ann Neurol; 1991 Feb; 29(2):124-31. PubMed ID: 1672807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR; Sage JI; Lang AE; Mark MH
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R; Ramirez Gómez CC; Micheli F
    J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770
    [No Abstract]   [Full Text] [Related]  

  • 16. Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.
    Fève A; Angelard B; Fénelon G; Logak M; Guillard A; Lacau Saint-Guily J
    Mov Disord; 1993 Apr; 8(2):217-9. PubMed ID: 8474494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P; Lenz FA; Chase TN
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 20. Dystonia--L-dopa responsive or juvenile parkinsonism?
    Rondot P; Ziegler M
    J Neural Transm Suppl; 1983; 19():273-81. PubMed ID: 6583312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.